Total Payments
$11,682
2023 Payments
$52.72
Companies
28
Transactions
114
Medicare Patients
222,109
Medicare Billing
$4.6M
Payment Breakdown by Category
Consulting$10,000 (85.6%)
Food & Beverage$1,682 (14.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $10,000 | 1 | 85.6% |
| Food and Beverage | $1,682 | 113 | 14.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Itamar Medical Inc | $10,000 | 1 | $0 (2020) |
| GlaxoSmithKline, LLC. | $249.90 | 20 | $0 (2019) |
| Novo Nordisk Inc | $185.78 | 13 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $173.57 | 15 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $146.66 | 8 | $0 (2018) |
| Astellas Pharma US Inc | $106.61 | 2 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $99.52 | 6 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $79.85 | 6 | $0 (2018) |
| Allergan Inc. | $73.95 | 5 | $0 (2017) |
| ARBOR PHARMACEUTICALS, INC. | $63.78 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $52.72 | 3 | Novo Nordisk Inc ($28.05) |
| 2021 | $29.53 | 2 | AbbVie Inc. ($16.16) |
| 2020 | $10,042 | 4 | Itamar Medical Inc ($10,000) |
| 2019 | $92.93 | 7 | GlaxoSmithKline, LLC. ($40.73) |
| 2018 | $389.08 | 25 | GlaxoSmithKline, LLC. ($76.34) |
| 2017 | $1,076 | 73 | Janssen Pharmaceuticals, Inc ($135.63) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Obesity | ||||||
| 08/03/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Obesity | ||||||
| 04/14/2023 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 10/21/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/25/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Obesity | ||||||
| 02/07/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Obesity | ||||||
| 02/04/2020 | Itamar Medical Inc | WatchPat (Device) | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| Category: Sleep Apnea testing | ||||||
| 01/09/2020 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $12.93 | General |
| 12/13/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Obesity | ||||||
| 10/28/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: Virology & Specialty Care | ||||||
| 10/18/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Obesity | ||||||
| 06/05/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: RESPIRATORY | ||||||
| 05/20/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: RESPIRATORY | ||||||
| 05/09/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: RESPIRATORY | ||||||
| 03/05/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: UROLOGY | ||||||
| 11/26/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/26/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: Gastroenterology | ||||||
| 09/24/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/27/2018 | Ironwood Pharmaceuticals, Inc | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Gastroenterology | ||||||
| 08/16/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: RESPIRATORY | ||||||
| 07/23/2018 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Diabetes | ||||||
| 07/09/2018 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: ADHD | ||||||
| 07/02/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 56 | 58,267 | 86,402 | $6.0M | $1.1M |
| 2022 | 73 | 61,221 | 90,986 | $5.4M | $1.2M |
| 2021 | 66 | 55,101 | 82,945 | $5.3M | $1.2M |
| 2020 | 59 | 47,520 | 69,752 | $5.5M | $1.2M |
Total Patients
222,109
Total Services
330,085
Medicare Billing
$4.6M
Procedure Codes
254
All Medicare Procedures & Services
254 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 4,347 | 5,708 | $572,332 | $93,847 | 16.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 4,873 | 7,029 | $561,793 | $91,491 | 16.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 5,313 | 8,792 | $565,607 | $90,520 | 16.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 5,459 | 10,186 | $180,409 | $85,296 | 47.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 2,421 | 2,860 | $459,120 | $82,370 | 17.9% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 1,430 | 1,730 | $421,734 | $69,570 | 16.5% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 193 | 566 | $179,090 | $57,907 | 32.3% |
| 83735 | Magnesium level | Office | 2023 | 5,343 | 8,859 | $356,895 | $57,708 | 16.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 4,963 | 7,287 | $385,090 | $55,229 | 14.3% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 1,852 | 2,560 | $260,670 | $42,247 | 16.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 3,138 | 4,476 | $263,730 | $42,233 | 16.0% |
| 84100 | Phosphate level | Office | 2023 | 5,343 | 8,855 | $266,930 | $40,826 | 15.3% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 2,095 | 2,526 | $226,098 | $37,057 | 16.4% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 1,348 | 1,348 | $143,532 | $25,413 | 17.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 234 | 378 | $80,460 | $22,896 | 28.5% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 1,852 | 2,559 | $138,960 | $22,467 | 16.2% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 496 | 691 | $106,131 | $17,273 | 16.3% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 893 | 1,212 | $99,540 | $15,990 | 16.1% |
| 82746 | Folic acid level, serum | Office | 2023 | 784 | 993 | $88,257 | $14,166 | 16.1% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 426 | 586 | $75,612 | $12,363 | 16.4% |
| 82670 | Measurement of total estradiol (hormone) | Office | 2023 | 313 | 401 | $64,444 | $10,890 | 16.9% |
| 83550 | Iron binding capacity | Office | 2023 | 834 | 1,159 | $61,848 | $9,826 | 15.9% |
| 82627 | Dehydroepiandrosterone (dhea-s) hormone level | Office | 2023 | 325 | 408 | $54,423 | $8,869 | 16.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 77 | 215 | $41,214 | $8,132 | 19.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 70 | 203 | $30,150 | $7,449 | 24.7% |
About Dr. Charles Powell, MD
Dr. Charles Powell, MD is a Family Medicine healthcare provider based in Irving, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760458897.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Powell, MD has received a total of $11,682 in payments from pharmaceutical and medical device companies, with $52.72 received in 2023. These payments were reported across 114 transactions from 28 companies. The most common payment nature is "Consulting Fee" ($10,000).
As a Medicare-enrolled provider, Powell has provided services to 222,109 Medicare beneficiaries, totaling 330,085 services with total Medicare billing of $4.6M. Data is available for 4 years (2020–2023), covering 254 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Irving, TX
- Active Since 02/28/2006
- Last Updated 08/24/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1760458897
Products in Payments
- WatchPat (Device) $10,000
- ANORO (Drug) $220.03
- XARELTO (Drug) $158.14
- BEVESPI AEROSPHERE (Drug) $109.73
- Saxenda (Drug) $98.18
- Myrbetriq (Drug) $95.79
- SOLIQUA (Drug) $87.06
- LINZESS (Drug) $74.53
- Otovel (Drug) $63.78
- Vascepa (Drug) $46.61
- Victoza (Drug) $40.91
- JANUVIA (Drug) $38.13
- FARXIGA (Drug) $36.93
- UTIBRON (Drug) $35.61
- Trintellix (Drug) $34.25
- Prolia (Biological) $30.50
- VIBERZI (Drug) $29.12
- Adzenys XR-ODT (Drug) $28.48
- Wegovy (Drug) $28.05
- Androgel (Drug) $28.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Irving
Cesar Torres, Md, MD
Family Medicine — Payments: $32,727
Family Medicine $32,727
Dr. Maria Biard, Md, MD
Family Medicine — Payments: $15,937
Family Medicine $15,937
Dr. James Anderson, Md, MD
Family Medicine — Payments: $14,112
Family Medicine $14,112
Dennis Pangtay, M.d, M.D
Family Medicine — Payments: $13,897
Family Medicine $13,897
Nisha Sharma, Md, MD
Family Medicine — Payments: $13,772
Family Medicine $13,772
Dr. Stephanie Elmore, M.d, M.D
Family Medicine — Payments: $13,091
Family Medicine $13,091